Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20191245 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Pioglitazone+Citalopram+Chlordiazepoxide;   Drug: Placebo+ Citalopram+ Chlordiazepoxide

Indicates status has not been verified in more than two years